European Heart Journal-Quality of Care and Clinical Outcomes

Article	Citations
Ambulance drive-thru troponin, ready to go?	80
Letter to the editor in response to Kobo et al. 2022	64
Evolving perspectives in personalized cardiovascular care	62
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor	62
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	52
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied	40
Association of lipoprotein(a) level and major adverse cardiovascular events in adult cancer survivors with atherosclerotic disease	36
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events	32
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–20	32
Secundum atrial septal defect closure in adults in the UK	32
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease	29
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes	28
Beyond biomarkers: the relevance of supporting evidence in the diagnosis of periprocedural myocardial infarction	28
Intracoronary imaging for percutaneous coronary intervention: worth the cost?	26
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings	26
Beyond the SMuRF-less paradox: disaggregation may restore clinical meaning	24
Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigm	23
Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations	23
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings	22
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations	21
Mitral valve prolapse: incidence and prognosis related to serum levels of sex hormone-binding globulin	21
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	21
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study	21
Mental disorders, mortality following myocardial infarction, and the impact of the COVID-19 pandemic in England: a cohort study	20
Mapping the modern heart failure epidemic: growing burden, root causes, and widening inequalities	20

Association between delayed statin initiation after high LDL-cholesterol detection and cardiovascular risk in general health screening examinees	20
Correction to: Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	19
Economic burden of cardiovascular disease in the United Kingdom	19
The rising burden of enterococcal endocarditis: insights from contemporary European data	19
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients	19
Correction to: Optimizing patient triage on the waiting list for transcatheter aortic valve replacement: the clinical utility of the cardiac damage staging system	19
Cost-effectiveness of population screening for aortic stenosis	18
Erratum to: Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data	17
Association of cumulative health status with subsequent mortality in patients with acute heart failure	17
Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	17
Letter to the editor in response to Sengupta et al. (2022)	16
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation	16
LDL-cholesterol lowering, the earlier the better: lessons from the real world	16
Prognostic impact of anaemia in patients undergoing aortic valve replacement: a nationwide study	16
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study	15
Impact of low physical activity on cardiovascular disease across regions and demographic groups: insights from the Global Burden of Disease Study	15
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22	15
Greenness exposure and mortality risk in a cardio-oncologic population	15
The beginning of wisdom is the definition of terms: counting heart failure hospitalizations	15
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study	15
Risk-standardized mortality metric to monitor hospital performance for chest pain presentations	15
Advanced maternal age at first delivery as a risk factor for long-term cardiovascular disease	14
Sex-based differences in heart failure development during STEMI hospitalization	14
Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations	14
Cancer and the risk of perioperative arterial ischaemic events	14
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	14
The semaglutide paradox in non-overweight diabetes: a benefit without explanation	14
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	14
Cost-effectiveness of atrial fibrillation screening programmes across European nations	14
Periprocedural myocardial infarction after coronary artery bypass grafting: defining what matters	13
Hospital admissions in the last year of life of patients with heart failure	13
First clinical experience with the Transthyretin Amyloidosis-Quality of Life questionnaire (ATTR-QoL): associations with clinical characteristics and established patient-reported outcomes	13
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry	13
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study	13
Multi-domain biomarkers for holistic care of cancer survivors	13
Clinical Outcomes in Hospitalized Patients with Cancer and New versus Preexistent Atrial Fibrillation	12
Ultrasound evaluation of placental volume and placental vascular indices in women developing hypertensive disorders in pregnancy compared to controls: a systematic review and meta-analysis	12
Large-scale AI analysis reveals missed opportunities in albuminuria testing and disease-modifying therapy implementation	12
Transcatheter vs. surgical mitral valve interventions in patients with prior coronary artery bypass grafting	12
A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation	12
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly	11
Clinical outcomes following invasive cardiovascular interventions in frail populations: a systematic review and meta-analysis	11
Quality of life and societal costs in patients with dilated cardiomyopathy	11
Current prevalence and remaining challenges of sodium-glucose cotransporter 2 inhibitors in patients with heart failure	11
Addressing the impact of social determinants of health in congenital heart disease	11
Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries	11
Cost-effectiveness of the ABCStroke pathway in ischaemic stroke care: a UK pilot analysis	11
National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients	11
Treating the patient, not just the valve: can we predict which transcatheter aortic valve implantation patients truly benefit?	11
Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021	11

POAF after CABG: early risk, landmark bias, and the case for selective anticoagulation	10
Validating national registry data for randomized trials: comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trial	10
Integrating cardiac biomarkers into the AHA PREVENT equations: impact on atherosclerotic cardiovascular disease risk stratification	10
RNA-targeted therapeutics in arterial hypertension	10
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project	10
Utility of patient-reported perception of symptom change in patients with acute decompensated heart failure in predicting post-discharge clinical outcomes: insights from KCHF registry	9
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	9
Bacteraemia and infective endocarditis following left-sided heart valve surgery	9
Beta-blockers in patients with uncomplicated arterial hypertension: data from the Campania Salute Network Registry	9
Suspected Non-ST-elevation acute coronary syndrome meeting rapid rule-out criteria: resource utilization, diagnostic yield, and clinical outcomes of hospital admission	9
The less lonely and the more satisfied you are, the merrier is … the heart!	8
Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 2019	8
Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence	8
Incidence, predictors, and prognostic impact of rehospitalization after transcatheter aortic valve implantation	8
Risk charts are not neutral: reconsidering threshold effects in SCORE2-based treatment eligibility	8
Impact of COVID-19 pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome	8
Elementary school performance of children with congenital heart disease: a Danish nationwide cohort study	8
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?	8
Non-invasive physiological assessment of intermediate coronary stenoses from plain angiography through artificial intelligence: the STARFLOW system	8
Optimizing anticoagulant therapy: is pharmacist-led intervention the best	8
Method validation of cardiopulmonary exercise testing: intra- and inter-device comparisons across four metabolic carts	8
Evaluation of a combined symptom-based questionnaire and capillary natriuretic peptides testing for early detection of heart failure: a Heart Failure Awareness Days nationwide screening study (DEPIC F	8
Association of baseline and changes in health-related quality of life with mortality following myocardial infarction: multicentre longitudinal linked cohort study	8
Editorial: impact of catheter-directed thrombolysis on the socioeconomic burden of pulmonary embolism in Germany a cost-effectiveness analysis: who dares wins	8
Ischaemic cerebrovascular events post-atrial fibrillation catheter ablation: a descriptive report on the ITHACA database	8
Severe LVOT obstruction in HCM: effects on exercise capacity and outcomes from cardiopulmonary exercise testing combined with stress echocardiography	8
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohort	8
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study	7
Regional disparities in heart transplant mortality in the USA	7
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	7
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China	7
Disparities in ST-elevation myocardial infarction diagnosis and management among patients with mental health conditions	7
Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy: are we there yet?	7
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data	7
Quality of care and long-term survival after ST-elevation myocardial infarction in adults with cancer	7
Measuring what matters in out-of-hospital cardiac arrest care	7
First systematic screening of cardiac amyloidosis in the elderly: findings and cost-effectiveness profile	7
Tricuspid transcatheter edge-to-edge repair for tricuspid valve regurgitation: a sex-based real-world analysis from the TRI-SPA registry	7
Mind the missed-fibrinolysis gap	7
Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence comple	7
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	7
Trends in atrial fibrillation-related mortality in Europe, 2008–2019	7
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco	7
Assessing the health impact of low seafood omega-3 intake on ischaemic heart disease: trends, demographic disparities, and forecasts	7
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings	7
Comprehensive risk factor management for hypertensive patients	7
Heart failure in an ageing world: closing the evidence-equity gap	7
Temporal trends in loss of expected lifetime associated with cardiovascular complications following newly diagnosed atrial fibrillation: a Danish nationwide cohort study from 2000 to 2022	7
Predictive factors of surgical repair technique in infants with coarctation of the aorta	7
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)	7
Comment on ‘association of menopausal hormone therapy with incident cardiovascular disease in women veterans’	6
Real-world evidence and quality improvement in heart failure and cardiomyopathies	6
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence	6
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges	6
Existing health disparities in congenital heart disease: the path forward to achieving health equity—A scientific statement of the European Association of Preventive Cardiology of the ESC	6
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	6
Adapting predictive risk models and preventive strategies across different socio-economic regions to reduce global cardiovascular burden	6
Inequality across the cardiac rehabilitation trajectory in Denmark: investigating key sociodemographic and health-related drivers	6
Unravelling the gaps in diagnosis and management of arrhythmogenic cardiomyopathy	6
Response to the correspondence ‘From composite events to clinical action: disentangling arrhythmia risk in a new Fabry CMR prognostic score’	6
Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013–2024): a systematic review of guidelines	6
One year healthcare consumption prior to sudden cardiac death	6
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	6
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry	6
A systematic assessment of the characteristics of randomized controlled trials cited by acute coronary syndrome clinical practice guidelines	5
Cardiovascular risk assessment and risk factor control in patients with hypertension in Europe: the SNAPSHOT study	5
Prognostic role of myocardial storage, hypertrophy, and inflammation/fibrosis in Fabry cardiomyopathy: a new predictive score including T1 values	5
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019	5
Population-based screening for conditions associated with juvenile sudden cardiac death: a systematic review and meta-analysis	5
The Italian Fabry Disease Cardiovascular Registry (IFDCR)	5
Non-steroidal anti-inflammatory drugs and oral anticoagulants in atrial fibrillation: common practice, avoidable harm	5
Economic evaluation of the Liverpool heart failure virtual ward model	5
Global burden of heart failure in older adults: trends, socioeconomic inequalities, and future projections from 1990 to 2035	5
Impact of catheter-directed thrombolysis on the socio-economic burden of pulmonary embolism in Germany: a cost-effectiveness analysis	5
Relationship between hospital mortality and readmission rates after transcatheter aortic valve replacement	5
Impact of intravascular ultrasound for coronary bifurcations treated with last-generation stents: insights from the ULTRA-BIFURCAT registry	5
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040	5
The assessment and management of patients with type 2 myocardial infarction: an international Delphi study	5
Association of socioeconomic status in the incidence, quality-of-care metrics, and outcomes for patients with cardiogenic shock in a pre-hospital setting	5
Catheter ablation as an adjunctive therapy to ICD implantation in Brugada Syndrome	5

Change in prevalence of ATTR variants in Italy: results from a national survey	5
Psoriasis and risk of new-onset degenerative valvular heart disease: a prospective cohort study	5
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies	5
Priority measures for implementation: an ESC pilot linking guidelines to practice	5
Myocarditis in 2025: ESC guidelines advance the field and highlight the opportunity for evidence to follow	5
Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021	5
The patient journey in chronic coronary syndromes with/without obstructive coronary arteries	5
Bridging the gaps in cardiac rehabilitation: from identifying inequalities to delivering fair, person-centred care	5
Potential Bias in Efficacy Estimates Due to Intercurrent Treatment Discontinuations	5
COP27 Climate Change Conference: urgent action needed for Africa and the world	4
Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis	4
Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis	4
The influence of social deprivation in infective endocarditis: a retrospective observational study of the London endocarditis research network	4
Should we routinely measure patient quality of life after acute coronary syndrome?	4
Primary prevention ICD: essential safeguard or personalized selectivity?	4
Association between quality of care indicators and clinical outcomes in patients undergoing transcatheter aortic valve implantation: insights from SWEDEHEART	4
From paper charts to precision prevention: why cardiovascular risk estimation must move online	4
Integrating cultural background into the psychological and social prevention of cardiovascular diseases	4
Marathons for women and sprints for men: shall we all run together?	4
The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes	4
A nationwide study of the economic burden of obstructive hypertrophic cardiomyopathy in France	4
When the pain persists: redefining quality of care in women with INOCA	4
Atrial fibrillation and risk of myocardial infarction in women and men: similar, yet so different	4
Inclusion and reporting by age, sex, and ethnicity in clinical studies of high-risk medical devices approved in the European Union	4
Cardiovascular outcomes and safety of semaglutide in non-overweight populations with type 2 diabetes: a comparison with dipeptidyl peptidase 4 inhibitors	4
Association of healthy sleep pattern with risk of recurrent cardiovascular events among patients with coronary heart disease	4
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands	4
Cardiopulmonary long-term effects 30 months after severe COVID-19 infection	4
Air Travel in Patients with Acute Coronary Syndromes or Heart Failure: Current Evidence, Guidance and Gaps	4
Correspondence to the European Heart Journal – Quality of Care and Clinical Outcomes in response to the paper by Warming et al. (2022): Atrial fibrillation and chronic obstructive pulmonary disease: d	4
Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019	4
De-frailing intervention for hospitalized cardiovascular patients in the TARGET-EFT randomized clinical trial	4
Optimizing patient triage on the waiting list for transcatheter aortic valve replacement: the clinical utility of the cardiac damage staging system	4
Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	4
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines	4
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries	4
Driving restrictions following defibrillator implantation: a nationwide register-linked survey study on the impact on employment, daily living, and driving behaviour	4
Correction to: The evolving landscape of atrial fibrillation: diagnosis and therapy	4
Feasibility of coronary access after transcatheter aortic valve implantation (TAVI): a systematic review and meta-analysis of observational studies	4
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	3
Heart failure clinical registries vs. registering the reality of heart failure	3
Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action	3
Mechanical circulatory support devices vs. standard medical therapy for treatment of myocardial infarction complicated by cardiogenic shock: a network meta-analysis	3
The impact of atrial fibrillation on prognosis in aortic stenosis	3
Atrial fibrillation—lost lifetimes and the urgent need for outcome-driven management	3
Evaluating TAVI quality indicators: critical insights from the SWEDEHEART experience and future directions	3
Letter to the Editor in Response to Sengupta et al. (2022)	3
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making	3
Bleeding risk using non-steroidal anti-inflammatory drugs in anticoagulated patients with atrial fibrillation: a nationwide cohort study	3
Atrial fibrillation screening and clinical outcomes: a meta-analysis of randomized controlled trials	3
A hidden problem: peripheral artery disease in women	3
Evolving Epidemiology of Cardiomyopathies at a National Referral Centre: a 30-Year Longitudinal Study	3
Heart valve disease in the modern era: a call for holistic, long-term management	3
Corrigendum to: Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF Gene	3
The controversy between atrial fibrillation subtypes and worsening heart failure	3
Educational inequalities in cardiovascular diseases and their mediating factors across different generations: a prospective cohort study	3
Development and validation of multivariable risk adjustment models for return of spontaneous circulation and survival to hospital discharge following out-of-hospital cardiac arrest in England	3
Psychiatric morbidity and work participation in patients with congenital ventricular septal defects: a case-controlled study	3
Comparison of mitral valve repair vs. replacement for mitral valve regurgitation	3
Editorial: Beyond obesity: metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	3
The association of temporal sequence in atrial fibrillation and chronic obstructive pulmonary disease diagnosis and mortality risk: Reply	3
Association of menopausal hormone therapy with incident cardiovascular disease in women veterans	3
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)	3
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk score	3
An early accumulation of serum uric acid confers more risk of heart failure: a 10-year prospective cohort study	3
Clinicoeconomic burden among heart failure patients with severely reduced ejection fraction after hospital admission: HF-RESTORE	2
Quality counts: revisiting anticoagulation after mechanical aortic valve replacement in patients with atrial fibrillation	2
Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings	2
Corrigendum to: Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	2
GLP-1 receptor agonists and clinical outcomes in patients with type 2 diabetes undergoing transcatheter aortic valve implantation	2
Transcatheter aortic valve implantation: the fountain of second youth?	2
Association of socioeconomic status with 30-day survival following out-of-hospital cardiac arrest in Scotland, 2011–2020	2
Uptitration of statin therapy in women and men: a population-based cohort study	2
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study	2
Preparation for cardiac procedures: a cross-sectional study identifying gaps between outpatients’ views and experiences of patient-centred care	2
Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study	2
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland	2
The quality of care and long-term mortality of out of hospital cardiac arrest survivors after acute myocardial infarction: a nationwide cohort study	2
Vaccines and myocardial injury in patients hospitalized for COVID-19 infection: the CardioCOVID-Gemelli study	2
Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality	2
Beyond obesity: metabolic status as a key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	2
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply	2
Clinical and economic outcomes following first-time myocardial infarction: a nationwide cohort study from the SWEDEHEART registry	2
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 in	2
European Society of Cardiology quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation	2
Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention	2
High risk of rehospitalization within 1 year following a pulmonary embolism—insights from the Danish nationwide registries from 2000–2020	2
Global, regional, and national burden of heart failure and its risk factors between 1990 and 2021 and projections to 2050: an analysis of the global burden of disease study	2
Patient–physician sex concordance in cardiovascular care: context matters	2
Heart failure in women of childbearing age: reading the signals behind the trendlines	2
Differential associations of cardiorenal-inflammatory markers with cardiac and cancer mortality in cancer survivors	2
Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: a UK perspective	2
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries	2
Characteristics, clinical management and outcomes of patients with acute myocardial infarction enrolled or not enrolled in a quality registry	2
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial	2